Experiments

Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).

• Restoring immune homeostasis in atherosclerotic plaques via inorganic violet phosphorus nano-immunotherapy.

  PMID 41494534 · PMC12866099 · Cell reports. Medicine · 2026 · 8 claims · 8 setups

  Full-text index only

  VPNS@P selectively accumulates in immune cells within atherosclerotic plaques (predominantly macrophages and monocytes, partly T and B cells) with minimal off-target uptake by non-immune vascular cells

  vpns@p cell-free raw264.7 bone-marrow-derived tem ros-scavenging cck-8

• A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2.

  PMID 41876554 · PMC13172340 · NPJ vaccines · 2026 · 8 claims · 8 setups

  Full-text index only

  The G1-C mRNA vaccine (RBD + membrane protein epitope) induces 8.2-fold higher WA1 RBD-specific IgG and 16.6-fold higher XBB.1.5 RBD-specific IgG than the RBD-only vaccine

  plasma pbmcs spleen bone elisa pseudovirus intracellular

• RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.

  PMID 39820365 · PMC11739599 · Nature communications · 2025 · 8 claims · 8 setups

  Has reproduction · 73

  RSK1 is a conserved, exploitable therapeutic dependency across MPN and secondary AML

  sorted mpn cd34+ aml bulk targeted mass